These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical and biochemical characteristics and genotype-phenotype correlation in Finnish variegate porphyria patients. von und zu Fraunberg M; Timonen K; Mustajoki P; Kauppinen R Eur J Hum Genet; 2002 Oct; 10(10):649-57. PubMed ID: 12357337 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of acute porphyrias. The importance of follow-up of patients and carriers]. Tasnádi G; Bor M; Pusztai A Orv Hetil; 2003 May; 144(19):933-8. PubMed ID: 12809070 [TBL] [Abstract][Full Text] [Related]
5. Penetrance and predictive value of genetic screening in acute porphyria. Baumann K; Kauppinen R Mol Genet Metab; 2020 May; 130(1):87-99. PubMed ID: 32067921 [TBL] [Abstract][Full Text] [Related]
6. Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. Innala E; Andersson C J Intern Med; 2011 May; 269(5):538-45. PubMed ID: 21198994 [TBL] [Abstract][Full Text] [Related]
7. Manifestation of acute intermittent porphyria in patients with chronic inflammatory bowel disease. Sieg I; Beckh K; Kersten U; Doss MO Z Gastroenterol; 1991 Nov; 29(11):602-5. PubMed ID: 1771936 [TBL] [Abstract][Full Text] [Related]
8. Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries. Prabahar MR; Manorajan R; Sathiyakumar D; Soundararajan P; Jayakumar M Hemodial Int; 2008 Jan; 12(1):34-8. PubMed ID: 18271838 [TBL] [Abstract][Full Text] [Related]
9. Mortality in patients with acute intermittent porphyria requiring hospitalization: a United States case series. Jeans JB; Savik K; Gross CR; Weimer MK; Bossenmaier IC; Pierach CA; Bloomer JR Am J Med Genet; 1996 Nov; 65(4):269-73. PubMed ID: 8923933 [TBL] [Abstract][Full Text] [Related]
10. [Acute intermittent porphyria in the practice of anesthesiology and intensive care]. Ershov AL Anesteziol Reanimatol; 2001; (1):64-6. PubMed ID: 11338527 [TBL] [Abstract][Full Text] [Related]
11. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks. Sardh E; Harper P; Andersson DE; Floderus Y Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613 [TBL] [Abstract][Full Text] [Related]
12. [Acute hepatic porphyria and its neurological syndrome]. Bont A; Steck AJ; Meyer UA Schweiz Med Wochenschr; 1996 Jan; 126(1-2):6-14. PubMed ID: 8571113 [TBL] [Abstract][Full Text] [Related]
13. [[35 Years of effort to improve the diagnosis of porphyria]. Kostrzewska E; Gregor A Przegl Lek; 1999; 56(9):576-8. PubMed ID: 10695362 [TBL] [Abstract][Full Text] [Related]
14. [Acute intermittent porphyria in the practice of an intensive care specialist]. Ershov AL Anesteziol Reanimatol; 1999; (2):51-5. PubMed ID: 10360075 [TBL] [Abstract][Full Text] [Related]
15. Early-onset chronic renal failure as a complication of acute intermittent porphyria. Laiwah AA; Mactier R; McColl KE; Moore MR; Goldberg A Q J Med; 1983; 52(205):92-8. PubMed ID: 6878621 [TBL] [Abstract][Full Text] [Related]
17. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria. Kostrzewska E; Gregor A Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651 [TBL] [Abstract][Full Text] [Related]
18. A family with acute intermittent porphyria. Billoo AG; Lone SW J Coll Physicians Surg Pak; 2008 May; 18(5):316-8. PubMed ID: 18541093 [TBL] [Abstract][Full Text] [Related]
19. [Acute intermittent porphyria: report on 17 patients with 49 attacks (author's transl)]. Schley G; Anlauf M; Bock KD Med Klin; 1976 Oct; 71(44):1891-7. PubMed ID: 995030 [TBL] [Abstract][Full Text] [Related]